After some early setbacks, AbbVie has scored a second straight victory in its AndroGel legal saga. On Friday, a federal jury sided with the drugmaker over plaintiff Robert Nolte and his legal team, ...
Jeffrey Konrad, a traffic consultant in Tennessee, started taking AbbVie’s heavily advertised testosterone drug AndroGel in 2010 and suffered a heart attack shortly thereafter. Now he’s one of 4,100 ...
Are you a male experiencing symptoms of low testosterone such as weight gain and a high-pitched voice? If so, you may want to look into a product by the name of AndroGel. This testosterone gel has ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...
ATLANTA (CN) - Drugmakers cannot dismiss antitrust claims stemming from their multimillion-dollar settlements to eliminate competing generic drugs, a federal judge ruled. In the 1990s, Solvay ...
ATLANTA (CN) – A federal judge dismissed the remaining claims in a nearly 10-year-old dispute over competition on AndroGel, a drug that boosts testosterone production. In the 1990s, Unimed ...
WASHINGTON, Sept 8 (Reuters) - The U.S. Federal Trade Commission on Monday sued Drugmakers AbbVie Inc and Teva Pharmaceuticals Industries Ltd for allegedly illegally preventing generic versions of ...
In late July, an Illinois jury came to a bizarre verdict in a case over an alleged link between heart attacks and AndroGel, a gel product used for treating low testosterone (or “low T”). The jury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results